Enhancement of tissue plasminogen activator-catalyzed plasminogen activation by Escherichia coli S fimbriae associated with neonatal septicaemia and meningitis. by Parkkinen, Jaakko et al.
Thrombosis and Haemostasis - © F. K. SchattauerVerlagsgesellschaft mbH (Stuttgart) 65 (5) 483-486 (1991) 
Enhancement of lissue Plasminogen 
Activator-Catalyzed Plasminogen Activation 
by Escherichia coli S Fimbriae Associated 
with Neonatal Septicaemia and Meningitis 
Jaakko Parkkinen 1, Jörg Hacker2, and Timo K. Korhonen 3 
From the 1 Departments of Medical Chemistry, 1 Clinical Chemistry and 3 General Microbiology, 
University of Helsinki, Finland, and the 2 1nstitute for Genetics and Microbiology, 
University of Würzburg, FRG 
Summary 
The effect of Escherichia coli strains isolated from blood and 
cerebrospinal fluid of septic infants on plasminogen activation was 
studied. These strains typically carry a filamentous surface 
protein, S fimbria, that has formerly been shown to bind to 
endothelial cells and interact with plasminogen. The. bacteria 
effectively promoted plasminogen activation by tissue plasmino-
gen activator (t-PA) which was inhibited by e-aminocaproic acid. 
A recombinant strain expressing S fimbriae accelerated t-PA-
catalyzed plasminogen activation to a similar extent as did the 
wild-type strains whereas the nonfimbriate recipient strain had 
no effect. After incubation with t-PA and plasminogen, the 
S-fimbriate strain displayed bacterium-bound plasmin activity 
whereas the nonfimbriate strain did not. Bacterium-associated 
plasmin generation was also observed with a strain expressing 
mutagenized S fimbriae that Iack the cell-binding subunit SfaS but 
not with a strain lacking the major subunit SfaA. Both t-PA and 
plasminogen bound to purified S fimbriae in a lysine-dependent 
manner and purified S fimbriae accelerated t-PA-catalyzed plas-
minogen activation. The results indicate that E. coli S fimbriae 
form a complex with t-PA and plasminogen which enhances the 
rate of plasminogen activation and generates bacterium-bound 
plasmin. This may promote bacterial invasion and persistence in 
tissues and contribute to the systemic activation of fibrinolysis in 
septicaemia. 
lntroduction 
Septicaemia caused by Gram-negative bacteria is commonly 
associated with activation of the haemostatic and fibrinolytic 
proteolytic cascades (1). Activation of fibrinolysis is generally 
thought to be secondary to disseminated intravascular coagulation 
(2). On the other hand, it was recently shown that endotoxin 
infusion in humans induces a rapid increase in tissue plasminogen 
activator (t·PA) activity in plasma which precedes the increase in 
the concentratioR of its inhibitor, PAI-1 (3). A corresponding 
early activation of the fibrinolytic system has also been observed 
in patients with fulminant meningococcal septicaemia as reflected 
by low plasma Ievels of plasminogen and arplasmin inhibitor (4). 
The critical stage in the activation of fibrinolysis, the t-PA-
catalyzed conversion of plasminogen to plasmin, proceeds only 
slowly in the fluid phase but is remarkably accelerated by complex 
formation of plasminogen and t-PA with fibrin (5). This is 
mediated by so-called Iysine-binding sites occurring in both 
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plasminogen (6) and t-PA (7, 8). Several Gram-negative bacteria 
have been recently described to bind plasminogen in a lysine-
dependent manner, but it is not known whether this promotes 
plasminogen activation (9, 10). 
To explore the possibility that bacteria causing septic infections 
might promote plasminogen activation, we have studied the effect 
of E. coli strains isolated from blood and cerebraspinal fluid of 
septic infants on t-PA-catalyzed plasminogen activation. The 
plasminogen-binding components identified in E. coli are 
filamentous surface proteins, fimbriae, that are generally thought 
to mediate bacterial adhesion to host cells and tissues (9). The 
strains causing septic neonatal infections typically carry S fimbriae 
(11) that are expressed by the bacteria in circulation during an 
experimental systemic infection (12) and bind to sialyloligosac-
charide structures on vascular endothelial cells (13) and epithelial 
cells of the choroid plexus and br~in ventricles (14). We describe 
here that these strains effectively enhance t-PA-catalyzed plas-
minogen activation. This is apparently dependent on complex 
formation of t-PA and plasminogen with S fimbriae and results to 
generation of bacterium-bound plasmin activity. 
Materials and Methods 
Materials 
Human Glu-plasminogen, single-chain t-PA, and goat polyclonal t-PA-
specific immunoglobulin G (IgG) were from Biopool (Umeä, Sweden). 
S-2251 was from KabiVitrum (Stockholm, Sweden). CNBr-fragmented 
fibrinogen was from Technoclone (Vienna, Austria). Rahbit polyclonal 
plasminogen-specific IgG was from Dakopatts {Ciostrup, Denmark). 
Europium-chelate and Enhancement solution were from Wallac 
Biochemical Laboratories (Turku, Finland). E-Aminocaproic acid 
(EACA) was from Sigma Chemical Co. (St. Louis, MO). Labeling of IgG 
with europium-chelate was carried out as described before (9). 
Bacterial Strains 
E. coli strains RK 262, RK 267, RK 304, and RK 327 of the serotype 
018ac:Kl:H7, RK 308 of the serotype R:Kl:H47, and RK 318 of the 
serotype 06: K+: H47 isolated from blood or cerebrospinal fluid of septic 
neonatal infants have been characterized in detail before (11). The 
recombinant strains harbouring plasmids encoding genes for wild-type 
S fimbriae [strain HB101 (pANN801-13)], mutagenized S fimbriae lac~ing 
the Ieetin subunit (Sfas-) [strain HB101(pANN801-1321)] or mutagemzed 
S fimbriae Jacking the major structural subunit (SfaA -) [ strain 
HB101(pANN801-1)] have also been described before (15). Thc cxpres-
sion of S fimbriae in the strains was confirmed by immunofluorcsccnce 
staining {16) and hemagglutination assay (17). The bacteria were culti-
vated on CFA agar supplemented with appropriate antibiotics in the casc 
of recombinant strains. For plasminogen activation assays, bacteria were 
suspended in PBS (10 mM phosphate buffer, pH 7.4, 150 mM NaCJ) and 
washed once. S fimbriae were purified by using deoxycholatc and 
concentrated urea as described before (17). 
0.8 RK304 
0.6 0.6 
0.4 0.4 
E 0,2 0.2 r::: 
tt) 
0 
..q- 0.0 
-
0 
CU 
30 60 90 120 30 60 90 120 
Q) 0.8 0,8 (.) HB1 01 (pANNB01-13} H8101 r::: 
CU 
..0 0.6 0.6 "-
0 
Cl) 
..0 0,4 0.4 <l: 
0.2 0.2 
0.0 0.0 
0 30 60 90 120 0 30 60 90 120 
Time (min) 
Fig. 1 Effect of E. coli strains on t-PA-catalyzed plasminogen activation. 
t-PA (35 ng/ml), plasminogen (45 !Jg/ml), and the plasmin substrate 
S-2251 were incubated with bacteria (lOS/ml) or CNBr-fragmented fibrin 
(30 !Jg/ml) in the absence (e) and presence (0) of 2 mM EACA and 
without any stimulator (6.). RK304, an OI8ac:Kl:H7 wild-type strain; 
HBIOl (pANN801-13), an S-fimbriate recombinant strain; HBlOl, the 
nonfimbriate recipient strain 
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Fig. 2 Generation of bacterium-bound plasmin activity. Bacteria were 
incubated with t-PA and plasminogen, washed, and incubated with 
S-2251. ControJ incubations were carried out with 2 mM EACA, without 
t-PA, and without plasminogen. The nonfimbriate strain HBlOl, the 
strain HB101 (pANN801-13) with wild-type S fimbriae, the strain HBlOl 
(pANN801-1321) with fimbriae Jacking the Ieetin subunit (Sfas-), and the 
strain HB101 (pANN801-1) Jacking the major fimbrial subunit (SfaA-) 
were studied 
Plasminogen Activation Assays 
Conversion of plasminogen to plasmin was foJlowed by the plasmin-
catalyzed hydrolysis of S-2251, a tripeptide (Val-Leu-Lys) connected at its 
carboxyl terminus to p-nitroaniline. Assays were performed at 3'JO C in 
microtitration wells in 200 ~Jl of PBS containing 0.02% 1\veen 80, 35 ng/ 
ml t-PA, 45 !Jg/ml plasminogen, and 0.3 mM S-2251 in the presence and 
absence of bacteria, CNBr*fragmented fibrinogcn, or . S fimbriae as 
indicated. Under the initial conditions, M4o5nm pcr t1mc squarcd is 
directly proportional to the rate of plasmin formation and a. straight linc is 
obtained (18). Aceeieration rate was calculatcd as thc rat1o of thc slope 
M vs. P. in the presence ofthe compound studicd ovcr that in its abscnce. 
Formation of bacterium-associated plasmin activity was studicd by 
incubating 109 bacteria, 20 ng t-PA, and 8 llg plasminogcn in 400 ~I of 
PBS containing 0.02% 1\veen 80 for 2.5 h at 37o C. Separate control 
incubations were performed in the presencc .of 2 mM E~CA, without 
t-PA and without plasminogen. The bactcna wcrc scutmcntatcd by 
centrifugation, washed once with PBS, and suspcndcd in 250 ~ll of PBS 
containing 0.2 mM S-2251. After incubation for 60 min at 37o C, bacteria 
were pelleted and absorbance of the supcrnatant (200 J,tl) was mcasured at 
405 nm. 
Binding Assays 
Purified S fimbriae, 10 tJg/ml in PBS, wcrc coatcd to polystyrene 
microtitration wells by incubating overnight at 4o C, thc wclls werc 
saturated with bovine serum albumin (BSA), 1 mg/ml for 2 h at 23° C, 
washed, and incubated with plasminogcn or t-PA in 100 !Jl of PBS 
containing 0.05% 1\veen 20 for 16 hat 4° C. Thc wclls wcrc washcd three 
times and incubated with europium-labclcd plasminogcn- or t-PA-spccific 
IgG, correspondingly, in 100 !J] of 50 mM Tris HCl buffcr, pH 7.8, 
containing 150 mM NaCI, 5 mg/ml BSA, 1 mg/ml bovinc gammaglobulin, 
and 0.05% Tween 20 for 1 h at 23° C with continuous shaking. Thc wells 
were washed, 100 !JI of Enhancement solution was addcd, and time-
resolved fluorescence was measured after 20 min in an Arcus Fluorometer 
(Wallac Biochemical Laboratories). 
Results 
The activation of plasminogen by t-PA was slow in the absence 
of any promoter whereas CNBr-fragmented fibrinogen at a 
concentration of 30 !Jg/ml enhanced it about 50-fold (Fig. 1). At a 
bacterial density of 108/ml, E. coli strains isolated from septic 
neonatal infections caused on an average a 10-fold acceleration of 
plasminogen activation (Fig. 1). A similar acceleration was 
observed with four of the six strains studied, whereas two of the 
strains displayed lower acceleration rates. One of the Iatter strains 
expressed also less S fimbriae as indicated by a weak hemaggluti-
nation activity, whereas the other strains produced . a strong 
hemagglutination. To find out whether the acceleration of plas-
minogen activation was mediated by S fimbriae, recombinant 
bacteria expressing S fimbriae were studied. The recombinant 
strain HB101(pANN801-13) that expresses wild·type S fimbriae 
caused a similar acceleration rate as did the wild-type strains, 
whereas the nonfimbriate recipient strain HB 101 had no effect on 
plasminogen activation (Fig. 1). Similarly to the accelerating 
effect of fibrin fragments, that of the S-fimbriate bacteria was to a 
major part inhibited in the presence of 2 mM EACA (Fig.l). 
This suggested that the interaction was mediated by Iysine-
binding sites occurring in t·PA and plasminogen (6-8). If either 
plasminogen or t-PA was omitted from the activation reaction, no 
hydrolysis of the plasmin substrate was observed. This indicated 
that the plasmin activity observed was not due to any endogenous 
plasminogen activator or plasmin-like activity in E. coli. 
To study whether the generated plasmin was attached to the 
bacteria, these were incubated together with plasminogen and 
t-PA, washed, and then incubated with the plasmin substrate 
S-2251. The recombinant strains HB10l(pANN801-13) with wild-
type S fimbriae and HB10l(pANN801-1321) with mutagenized 
S fimbriae lacking the Ieetin subunit (SfaS-) displayed bacterium-
bound plasmin activity (Fig. 2). In contrast, the recombinant 
strain HB101(pANN801-l) lacking the major fimbrial subunit 
(SfaA -) and the nonfimbriate strain HB101 exhibited only margi-
nal activity (Fig. 2). The formation of bacterium-bound plasmin 
activity was to a major part inhibited in the presence of EACA. In 
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Fig. 3 Binding of t-PA and 
plasminogen to imrnobilized 
S fimbriae and the effect of 
purified S fimbriae on plasmi-
nogen activation. (A) Plasmi-
nogen and (B) t-PA were 
incubated in microtitration 
wells coated with purified S 
fimbriae in the absence (0) 
and presence (e) of 10 mM 
EACA and in wells coated 
with albumin (~). Binding of 
the proteins was detennined 
by fluoroimmunoassay. ( C) 
t-PA (35 J.Lg/ml), plasmino-
gen (45 ~glml), and S-2251 
were incubated with S fim-
briae (200 J.Lg/ml) (e) and 
without them ( 0) 
the absence of either t-PA or plasminogen, no plasmin-like 
activity was observed {Fig. 2). The plasmin activity on the strain 
HB101(pANN801-1321) was lower than that on the strain 
HB101(pANN801-13), but the fonner strain also expresses sig-
nificantly less S fimbriae than does the latter (15). 
Since the experiments with the recombinant bacteria strongly 
suggested that the enhancement of plasminogen activation by the 
wild-typestrainswas mediated by S fimbriae, these were studied 
in a purified form for binding of plasminogen and t-PA and for 
acceleration of plasminogen activation. Both plasminogen and 
t-PA bound in a concentration-dependent manner to immobilized 
S fimbriae as detected by europium-labeled plasminogen- and 
t-PA-specific antibodies, correspondingly (Fig. 3). The binding of 
plasminogen was almost completely inhibited with 10 mM 
EACA, and an inverted plot of the binding curve suggested a 
dissociation constant of about 40 Jlg/ml (0.4 J.LM). The majority of 
the binding of t-PA to S fimbriae was also inhibited with 10 mM 
EACA, and the apparent dissociation constant of the binding was 
about 3 Jlg/ml (40 nM). Purified S fimbriae enhanced t-PA-
catalyzed plasminogen activation in a dose-dependent manner, 
the acceleration rate being about 10-fold at a fimbrial concentra-
tion of 200 Jlg/ml (Fig. 3). 
Discussion 
The results of the present study indicate the presence of surface 
components in septigenic E. coli that bind both plasminogen and 
t-PA in a lysine-dependent manner and enhance plasminogen 
activation. The strains studied had been isolated from neonatal 
infants with septicaemia and meninigitis and included represen-
tatives of serotype 018: K1, which is the major serotype of E. coli 
causing septic neonata1 infections (11). The enhancing effect of 
these bacteria on t-PA-catalyzed plasminogen activation was at 
least partially mediated by S fimbriae, a filamentaus surface 
protein typically occurring in the 018:K1 strains (11), as indi-
cated by the following findings. Firstly, the recombinant strain 
expressing S fimbriae accelerated plasminogen activation to a 
similar extent as did the S-fimbriate wild-type strains, whereas the 
nonfimbriate recipient str~in had no effect. Secondly, purified 
S fimbriae had an accelerating effect on plasminogen activation. 
Plasminogen activation evidently takes place on the bacterial 
surface as purified S fimbriae bound both plasminogen and t-PA 
in a lysine-dependent manner and, after incubation with t-PA and 
plasminogen, S-fimbriate bacteria displayed bacterium-bound 
plasmin activity. 
S fimbriae are about 7 nm thick and 0.5-1 J.I.ID long protein 
filaments that consist of a major structural subunit with a 
molecular weight of 17 kDa (SfaA) and of three minor proteins 
(SfaS, SfaG, SfaH) (15, 17). The minor subunit SfaS, a 14.9 kDa 
protein (19), possesses a-sialyl-ß-2,3-galactoside-specific binding 
activity and mediates bacterial binding to host cells (13-15). The 
findings of the present study that .the recombinant strains ex-
pressing either wild-type S fimbriae or fimbriae lacking the SfaS 
protein accelerated plasminogen activation, whereas the strain 
that Jacked the SfaA protein was ineffective, suggest that the 
SfaA protein is involved in the complex formation with the 
fibrinolytic components. The possible roJe of the minor subunits 
SfaG and SfaH in plasminogen activation remains to be deter-
mined. However, our results indicate that S fimbriae are mul-
tifunctional proteins and suggest that their pathophysiological 
function may not be restricted to bacterial adhesion to host cells. 
Vascular endothelium is a target tissue for endotoxin effects, 
either directly or through secondary mediators (20). Endothelial 
cells also play a crucial part in regulation of coagulation and 
fibrinolysis by synthetising promoters and inhibitors of both 
systems and providing binding sites for them (21). In this respect 
it is of interest that S fimbriae also bind to human endothelial cells 
by their Ieetin activity (13). Bacterial adhesion to the endothelium 
may have pathophysiological importance by resisting clearance of 
bacteria by the blood flow to organs with reticuloendothelial 
tissue and by propagating their extravasation. On the other hand, 
it may also provide S-fimbriate bacteria with high local concentra-
tions of t-PA that is produced as an early effect of endotoxaemia 
(3). 
Bacterium-bound plasmin activity may play a pathogenic role 
in bacterial invasion and persistence in tissues. Besides fibrin, 
plasmin effectively degrades various extracellular matrix proteins, 
such as. fibronectin, laminin, and proteoglycan core proteins, and 
also promotes collagenolysis by activating procollagenase (22). In 
fact, cell surface-associated plasmin formation is regarded as an 
important mechanism in pericellular proteolysis of invasive ani-
mal cells, particularly in tumor cell invasion (22-24). Occurrence 
of bacterial surface-associated plasmin generation may therefore 
suggest that pathogenic bacteria utilize the host fibrinolytic 
system for tissue invasion. The binding sites of plasmin on the 
bacteria, fimbrial filaments, are very stable protein assernblies 
and we have not observed any degradation or loss of their cell-
binding function after plasmin treatments (9, J. Parkkinen and T. 
K. Korhonen, unpublished results). It is also unlikely that plasmin 
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would deteriorate the polysaccharide shield of encapsulated 
bacteria. 
The observation that a number of Gram-negative bacteria, 
many of which important human pathogens, bind plasminogen in 
a lysine-sensitive manner (10) suggests that other pathogenic 
bacteria may also enhance plasminogen activation similarily to 
S-fimbriate E. coli. This might be a contributing factor in the 
systernic fibrinolytic state often accompanying Gram-negative 
septicaemia. 
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